跳轉至內容
Merck

33-047

PI 3-激酶3步式HTRF®检测

The PI 3-Kinase 3-Step HTRF Assay is a high-performance assay kit that provides a universal method for testing all Class I PI3-Kinases in a homogeneous format.

同義詞:

3步式HTRF检测, PI 3-激酶检测

登入 查看組織和合約定價

選擇尺寸

暫時無法取得訂價和供貨情況

關於此項目

分類程式碼代碼:
12161503
eCl@ss:
32161000
NACRES:
NA.84

跳轉至

技術服務
需要援助?我們經驗豐富的科學家團隊隨時樂意為您提供支援。
讓我們為您提供幫助

品質等級

物種活性

human, mouse

製造商/商標名

HTRF®
Upstate®

技術

activity assay: suitable (kinase)

NCBI登錄號

UniProt登錄號

檢測方法

fluorometric (HTRF)

運輸包裝

dry ice

基因資訊

human ... PIK3CA(5290)

比較類似項目

查看完整比較

Show Differences

1 of 4

本產品
33-03614-782-MSRP0233
technique(s)

activity assay: suitable (kinase)

technique(s)

activity assay: suitable (kinase)

technique(s)

activity assay: suitable (kinase)

technique(s)

activity assay: suitable

species reactivity

human, mouse

species reactivity

mouse, human

species reactivity

-

species reactivity

-

manufacturer/tradename

HTRF®

manufacturer/tradename

HTRF®, Upstate®

manufacturer/tradename

Upstate®

manufacturer/tradename

Sigma-Aldrich

NCBI accession no.

NM_006218.2

NCBI accession no.

NM_006218.2

NCBI accession no.

NM_006218.2

NCBI accession no.

U79143 (p110alpha), XM_043865 (p85alpha)

UniProt accession no.

P42336

UniProt accession no.

P42336

UniProt accession no.

P42336

UniProt accession no.

P42336

detection method

fluorometric (HTRF)

detection method

fluorometric (HTRF)

detection method

-

detection method

-

一般說明

磷脂酰肌醇-4,5-二磷酸3激酶催化亚基α(PIK3CA)基因定位于人类染色体3q26.32。该基因编码IA类PI3激酶的催化亚基p110α。PI3K信号通路调节多种细胞活动和特性,包括增殖、存活、凋亡、运动和形态。PIK3CA基因的突变或过表达与各种人类实体肿瘤的发展有关,包括头颈癌或咽喉癌和卵巢癌。

應用

PI 3-激酶3步式HTRF®检测已用于测定磷脂酰肌醇3-激酶(PI3K)δ抑制剂(如MSD-496486311、MSD126796721、ideelalisib和duvelisib)对PI3K α、β、γ和δ异构体的体外抑制效力

生化/生理作用

靶标亚家族:PI3K/PI4K

包裝

试剂盒容量:10,000孔

準備報告

在-70°C下可保存12个月

其他說明

4X反应缓冲液

PIP2(底物;1mM储备液)

DM A反应缓冲液

DM B反应缓冲液

DM C反应缓冲液

BPIP3

终止试剂
研究类别
细胞凋亡 & 癌症
研究子类别
肿瘤学

法律資訊

HTRF is a registered trademark of Cis Bio International
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Robbie L McLeod et al.
The Journal of pharmacology and experimental therapeutics, 369(2), 223-233 (2019-02-26)
We leveraged a clinical pharmacokinetic (PK)/pharmacodynamics (PD)/efficacy relationship established with an oral phosphatidylinositol 3-kinase (PI3K)δ inhibitor (Idelalisib) in a nasal allergen challenge study to determine whether a comparable PK/PD/efficacy relationship with PI3Kδ inhibitors was observed in preclinical respiratory models of
Andreas G Bader et al.
Nature reviews. Cancer, 5(12), 921-929 (2005-12-13)
There have long been indications of a role for PI3K (phosphatidylinositol 3-kinase) in cancer pathogenesis. Experimental data document a requirement for deregulation of both transcription and translation in PI3K-mediated oncogenic transformation. The recent discoveries of cancer-specific mutations in PIK3CA, the
Wanglong Qiu et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 12(5), 1441-1446 (2006-03-15)
Recent studies have reported high frequencies of somatic mutations in the phosphoinositide-3-kinase catalytic alpha (PIK3CA) gene in several human solid tumors. Although gene amplifications of PIK3CA have been reported in head and neck squamous cell carcinoma (HNSCC), small mutation of

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務